Xydalba is an antibiotic used in adults and children aged 3 months and older to treat acute (short-term) bacterial infections of the skin and of skin structures (tissue below the skin) such as cellulitis (inflammation of the deep skin tissue), skin abscesses and wound infections. It contains the active substance dalbavancin.
Therapeutic Indication
### Therapeutic indication Treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.
Therapeutic Area (MeSH)
N/AATC Code
J01XA04
ATC Item
dalbavancin
Pharmacotherapeutic Group
Antibacterials for systemic use
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| dalbavancin hydrochloride | N/A | 达巴万星 |
EMA Name
Xydalba
Medicine Name
Xydalba
Aliases
N/ANo risk management plan link.
